[1]
Silverberg, J.I., Cork, M., Wollenberg, A., Katoh, N., Steffensen, L.A., Kurbasic, A., Olsen, C.K., Kuznetsova, A., ?sterdal, M.L., Vilsb?ll, A.W. and Deleuran, M. 2020. Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s98. DOI:https://doi.org/10.25251/skin.4.supp.98.